Protalex, Inc. Announces Completion of Dosing Patients in 4th Cohort of Its Phase 1b Dose Escalation Study of PRTX-100 in Patients With Active Rheumatoid Arthritis
January 17, 2012 09:00 ET
|
Protalex, Inc.
SUMMIT, N.J., Jan. 17, 2012 (GLOBE NEWSWIRE) -- Protalex, Inc. (OTCBB:PRTX), a clinical stage biopharmaceutical company which is engaged in developing a class of drugs for treating autoimmune and...
Protalex, Inc. Announces Enrollment of First Patients in 4th Cohort of Its Ongoing Phase 1b Dose Escalation Study of PRTX-100 in Patients With Active Rheumatoid Arthritis
June 27, 2011 08:00 ET
|
Protalex, Inc.
SUMMIT, N.J., June 27, 2011 (GLOBE NEWSWIRE) -- Protalex, Inc (OTCBB:PRTX), a clinical stage biopharmaceutical company which is engaged in developing a class of drugs for treating autoimmune and...
Protalex, Inc. Announces Enrollment of First Patients in 3rd Cohort of Its Ongoing Phase 1b Dose Escalation Study of PRTX-100 in Patients With Active Rheumatoid Arthritis
March 03, 2011 08:00 ET
|
Protalex, Inc.
SUMMIT, N.J., March 3, 2011 (GLOBE NEWSWIRE) -- Protalex, Inc (OTCBB:PRTX), a clinical stage biopharmaceutical company which is engaged in developing a class of drugs for treating autoimmune and...
Protalex, Inc. Announces 1 for 5 Reverse Stock Split and Preferred Stock Authorization
December 07, 2010 16:05 ET
|
Protalex, Inc.
SUMMIT, N.J., Dec. 7, 2010 (GLOBE NEWSWIRE) -- Protalex, Inc. (OTCBB:PRTX), a clinical stage biopharmaceutical company which is engaged in developing a class of drugs for treating autoimmune and...
Protalex, Inc. Announces Dose Escalation of First Patients in 2nd Cohort of Its Ongoing Phase 1b Study of PRTX-100 in Patients With Active Rheumatoid Arthritis
October 21, 2010 08:30 ET
|
Protalex, Inc.
SUMMIT, N.J., Oct. 21, 2010 (GLOBE NEWSWIRE) -- Protalex, Inc. (OTCBB:PRTX), a clinical stage biopharmaceutical company which is engaged in developing a class of drugs for treating autoimmune and...
Protalex, Inc. Announces Dosing of First Patient in a Phase 1b Study of PRTX-100 in Patients With Active Rheumatoid Arthritis
August 20, 2010 08:00 ET
|
Protalex, Inc.
SUMMIT, N.J., Aug. 20, 2010 (GLOBE NEWSWIRE) -- Protalex, Inc. (OTCBB:PRTX), a clinical stage biopharmaceutical company engaged in developing a class of biopharmaceutical drugs for treating autoimmune...
Protalex Appoints Victor S. Sloan, M.D. as Senior Vice President and Chief Medical Officer
July 26, 2005 16:00 ET
|
Protalex, Inc.
NEW HOPE, Pa., July 26, 2005 (PRIMEZONE) -- Protalex, Inc. (OTCBB:PRTX) today announced that Victor S. Sloan, M.D., FACR, FACP has joined the company as Senior Vice President and Chief Medical...